Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China · Delayed Price · Currency is CNY 11.87
+0.04 (0.34%)
Feb 4, 2026, 10:15 AM CST
SHE:002728 Revenue
Teyi Pharmaceutical Group Co.,Ltd had revenue of 200.71M CNY in the quarter ending September 30, 2025, with 41.49% growth. This brings the company's revenue in the last twelve months to 924.04M, up 18.84% year-over-year. In the year 2024, Teyi Pharmaceutical Group Co.,Ltd had annual revenue of 687.79M, down -35.55%.
Revenue (ttm)
924.04M
Revenue Growth
+18.84%
P/S Ratio
6.39
Revenue / Employee
689.07K
Employees
1,341
Market Cap
5.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 687.79M | -379.43M | -35.55% |
| Dec 31, 2023 | 1.07B | 180.64M | 20.38% |
| Dec 31, 2022 | 886.57M | 128.41M | 16.94% |
| Jan 1, 2022 | 758.16M | 125.47M | 19.83% |
| Dec 31, 2020 | 632.70M | -288.43M | -31.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition